These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1763443)

  • 1. [Postradiation secondary glaucoma and prevention measures].
    Brovkina AF; KaplinaAV ; Zarubeĭ GD
    Vestn Oftalmol; 1991; 107(5):16-20. PubMed ID: 1763443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of ciliochoroidal melanomas with a medical narrow proton beam].
    Brovkina AF; Zarubeĭ GD
    Vestn Oftalmol; 1986; 102(3):30-3. PubMed ID: 3014703
    [No Abstract]   [Full Text] [Related]  

  • 3. [Secondary glaucoma during treatment of certain neoplasms of the visual system (author's transl)].
    Maciejewski Z
    Klin Oczna; 1978 Dec; 48(12):675-6. PubMed ID: 732221
    [No Abstract]   [Full Text] [Related]  

  • 4. Ciliochoroidal melanomas treated with a narrow medical proton beam.
    Brovkina AF; Zarubei GD
    Arch Ophthalmol; 1986 Mar; 104(3):402-4. PubMed ID: 3006648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of beta-ray therapy in the treatment of choroidal and ciliary body melanomas].
    Grange JD; Gérard JP; Ragab M; Delaroche G; Jean-Louis B; Bievelez B; Sentenac I; Baute B
    Ophtalmologie; 1989; 3(3):175-9. PubMed ID: 2641104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trans-scleral resection of the ciliary body and choroidal melanoma].
    Romanowska-Dixon B; Starzycka M; Pogrzebielski A
    Klin Oczna; 2000; 102(5):323-6. PubMed ID: 11286105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
    Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W
    Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neovascular glaucoma following proton-beam therapy. Case report].
    D'Hermies F; Meyer A; Morel X; Lumbroso L; Levy C; Desjardins L; Frau E; Halhal M; Elmaleh C; Berges O; Gauthier JB; Ferrand R; Delacroix S; Schlienger P; Schwarz L; Habrand JL; Mazeron A; Renard G
    J Fr Ophtalmol; 2001 Jan; 24(1):95-101. PubMed ID: 11240479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
    Detorakis ET; Engstrom RE; Wallace R; Straatsma BR
    Ophthalmology; 2005 Mar; 112(3):505-10. PubMed ID: 15745782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panretinal photocoagulation for radiation-induced ocular ischemia.
    Augsburger JJ; Roth SE; Magargal LE; Shields JA
    Ophthalmic Surg; 1987 Aug; 18(8):589-93. PubMed ID: 3658314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matched group study of surgical resection versus cobalt-60 plaque radiotherapy for primary choroidal or ciliary body melanoma.
    Augsburger JJ; Lauritzen K; Gamel JW; DeBrakeleer DJ; Lowry JC; Eisenman R
    Ophthalmic Surg; 1990 Oct; 21(10):682-8. PubMed ID: 2250849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis.
    Hirasawa N; Tsuji H; Ishikawa H; Koyama-Ito H; Kamada T; Mizoe JE; Ito Y; Naganawa S; Ohnishi Y; Tsujii H
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):538-43. PubMed ID: 17141971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular complications after iodine brachytherapy for large uveal melanomas.
    Puusaari I; Heikkonen J; Kivelä T
    Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].
    Grange JD; Gerard JP; Ragab M; Quintero P; Delaroche G; Jean-Louis B; Sentenac I; Fontaniere B; Bievelez B
    Bull Soc Ophtalmol Fr; 1989 May; 89(5):679-82. PubMed ID: 2590984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton beam therapy and iris neovascularisation in uveal melanoma.
    Boyd SR; Gittos A; Richter M; Hungerford JL; Errington RD; Cree IA
    Eye (Lond); 2006 Jul; 20(7):832-6. PubMed ID: 16167079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary glaucoma after cobalt therapy of a choroidal melanoma].
    Zygulska-Machowa H; Ksiezyk ; Maciejewski Z; Gedliczka T
    Klin Oczna; 1991 Jan; 93(1):16-8. PubMed ID: 2046279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular collision tumour: case report and literature review.
    Coupland SE; Dodson A; Liu H; Du MQ; Angi M; Damato BE
    Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1383-8. PubMed ID: 23232651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.
    Finger PT; Berson A; Szechter A
    Ophthalmology; 1999 Mar; 106(3):606-13. PubMed ID: 10080222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral uveal melanoma: a series of four cases.
    Hadden PW; Damato BE; McKay IC
    Eye (Lond); 2003 Jul; 17(5):613-6. PubMed ID: 12855969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.